Spots Global Cancer Trial Database for First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
Official Title: First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
Study ID: NCT00537901
Study Description
Brief Summary: First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Shouki Bazarbashi, MD
Affiliation: KFSH & RC
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
